Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Cancer Cell ; 17(3): 273-85, 2010 Mar 16.
Article in English | MEDLINE | ID: mdl-20227041

ABSTRACT

The p53 gene is mutated in many human tumors. Cells of such tumors often contain abundant mutant p53 (mutp53) protein, which may contribute actively to tumor progression via a gain-of-function mechanism. We applied ChIP-on-chip analysis and identified the vitamin D receptor (VDR) response element as overrepresented in promoter sequences bound by mutp53. We report that mutp53 can interact functionally and physically with VDR. Mutp53 is recruited to VDR-regulated genes and modulates their expression, augmenting the transactivation of some genes and relieving the repression of others. Furthermore, mutp53 increases the nuclear accumulation of VDR. Importantly, mutp53 converts vitamin D into an antiapoptotic agent. Thus, p53 status can determine the biological impact of vitamin D on tumor cells.


Subject(s)
Cholecalciferol/metabolism , Tumor Suppressor Protein p53/genetics , Vitamin D Response Element/physiology , Apoptosis , Cell Line, Tumor , Cell Nucleus/metabolism , Chromatin Immunoprecipitation , Gene Expression Regulation, Neoplastic , Humans , Oligonucleotide Array Sequence Analysis , Promoter Regions, Genetic , Transcriptional Activation
SELECTION OF CITATIONS
SEARCH DETAIL
...